AKT2 and diabetic kidney disease: Godel et al. (2011) found that mTORC2 was essential for podocyte adaptation and foot-process reorganization in diabetic nephropathy and Canaud et al. (2013) indicated that AKT2 activation by mTORC2 is required for podocyte viability and function in nephron reduction-induced renal disease.